Package/Label Display Panel 1.7 mg Pen PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 0169- 4517 -14 List 451714 1.7 mg wegovy (semaglutide) injection 1.7 mg/0.75 mL Use Wegovy 1 time a week 4 Single-Dose Prefilled Pens Each pen delivers a single dose of 1.7 mg semaglutide For subcutaneous use only Single-Dose only Rx only Contains: 4 Wegovy pens, Product Literature
Instead of making GLP-1 tracking feel like another spreadsheet or macro program, MeAgain gives users a friendlier way to stay engaged with shot day, food noise, protein, hydration, side effects, progress, and consistency
You want microdose or oral GLP-1 options
According to incomplete statistics, sales of Novo Nordisk's semaglutide have been soaring year after year, with 2023 sales surpassing $21.2 billion, making it the first GLP-1 drug to join the "billion-dollar club." Its market position is quickly catching up with Merck's Keytruda, and it has the potential to become the next "blockbuster" drug
Ivim Health itself is the technology layer: it runs the app, schedules consultations, and coordinates care, but it is not your prescriber
No Phase I human safety trials or Phase II efficacy studies exist for BPC-157 in gastroparesis as of 2026